TrialTrials2024

Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial.

Mitra Soltani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.